Individuals with a clinical, research, education, or scientific interest in the effective use of antimicrobials are entitled to access content on this site (free of charge).
Healthcare, Academic, Patient advocacy and Commercial Organisations are invited to join GASPH as Global Partners. An Organisation registering as a Partner must confirm and agree to all terms of GASPH Terms of Engagement.
Only Partner Organisations can submit resources.
A Partner Organisation must nominate a named representative to sit on the GASPH Global Advisory Board. Representatives on the Board will act in the interests of the Hub, offer expertise both in relation to their economic territory and on behalf of their Partner Organisation.Register here
Since 1996, the DSPRUD has been in the forefront, in promoting rational use of medicines especially focusing on antibiotics and expounding the objectives to the medical, health and general public through a multi pronged strategy which includes contributing to policy, advocacy, training programmes for doctors, pharmacists and nurses; research and public education
The link between antibiotic use and resistance is clear. Consequently, concerns about inappropriate antibiotic prescribing has never been greater. Reversal of resistance problems is often feasible by changing patterns of antibiotic use. Audits repeatedly show tremendous variations in standards for antibiotic prescription, but the common topic is one of unnecessary use. With these facts in mind, a group of like-minded researchers have formed the European Study Group for Antibiotic Policies. ESGAP has gained official recognition from the ESCMID Executive Committee and elected its first executive officers at the 9th ECCMID, 1999, Berlin, Germany.
The group has since then promoted education and research activities on the topic of antimicrobial stewardship, and aims at sharing knowledge and experiences on its open virtual learning community platform.
The EBRD is owned by 71 countries, as well as the European Union and the European Investment Bank. Each shareholder is represented on the Board of Governors, which has overall authority over the Bank.
A clearly defined set of standards governs all our work as we strive to develop a healthy investment climate and promote environmentally and socially sound and sustainable development.
FDI World Dental Federation (FDI) serves as the principal representative body for more than one million dentists worldwide and has a bold vision to lead the world to optimal oral health. FDI is one of the oldest organizations in the field of dentistry and its membership comprises some 200 national dental associations and specialist groups in over 130 countries.
The Federation was formed from an amalgamation of existing societies representing different infectious diseases societies in Southern African. In 2020, Federation member societies include the Infectious Diseases Society of Southern Africa (IDSSA), Infection Control Society of South Africa (ICSSA), South African Society for Clinical Microbiology (SASCM) and Southern African Society of Paediatric Infectious Diseases (SASPID). The societies maintain their individual areas of expertise and identities yet share administrative support.
The Global Alliance for Infections in Surgery is an independent alliance promoted in 2016 by the World Society of Emergency Surgery (WSES), for a cohesive and global approach to promoting research and education in the field of infections in surgery.
The Global Alliance for Infections in Surgery aims to include all professionals involved in this battle, including epidemiologists and infection control specialists, infectious diseases specialists, hospital pharmacists, pharmacologists, microbiologists, intensivists, surgeons, and nurses.
The mission of Infections in Surgery is to educate healthcare providers promoting the standards of care in managing surgical infections worldwide.
Infection Control Academy of India (IFCAI), established in 2016, is the leading not-for-profit organization in India working on the promotion of infection prevention and control. IFCAI’s vision is to train 1.00,000 healthcare professionals in infection prevention and control by 2025 in India and low-resource countries, and its mission is to create a safer world through the prevention of infection. IFCAI created an academic pathway to build the capacity of Infection preventionists for LMIC. The flagship program of IFCAI is a pioneering Diploma in Infection Prevention and Control (www.pgdipc.com) at the Post Graduate level, offered in collaboration with the University of Hyderabad (www.uohyd.ac.in).
IFCAI is also a key stakeholder in drafting and executing AMR containment plans in India.
The academy is already in collaboration worldwide with several Universities, Professional associations, Civil society organizations, Healthcare institutions, Social entrepreneurs and Passionate individuals with a focus on IPC, WASH & AMR to improve IPC, and WASH practices and contain AMR.
We are open to collaborations.
ICAN is the largest infection prevention and control organisation in Africa that addresses related programmes across our continent and actively supports IPC programmes across Africa to reduce healthcare associated infections including outbreaks such as Ebola and cholera on the continent.
Our vision is an African continent where safe patient care is ensured for all with the implementation of strong infection control programmes. Therefore, ICAN exists to promote and facilitate the establishment of infection control programmes, achievement and maintenance of infection reduction, including healthcare associate infections, and promote antimicrobial stewardship activities through education by working with infection prevention structures in Africa and other International health related associations.
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Our purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. IDSA promotes comprehensive responses to antimicrobial resistance, and IDSA members care for patients with multidrug resistant infections, lead antimicrobial stewardship and infection prevention and control programs, and conduct research to develop new tools in the fight against AMR.
ICARS’ mission is to partner with low- and middle-income countries’ ministries and research institutions to co-develop and test cost-effective, context-specific AMR solutions with potential for scale-up across the One Health spectrum, building on National Action Plans, and informed by intervention and implementation research. ICARS works top-down with governments and policymakers and bottom-up with practitioners and stakeholders to identify and address AMR priorities. This is accompanied by capacity building to deliver projects at a country level, and partnerships with public and private, national and regional stakeholders to avoid duplication and support uptake of the evidence generated.
ISAC was founded in 1961 and aims to advance the education and the science of therapy of infection through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives. ISAC currently has a worldwide membership composed of 95 national and regional societies. The society is governed by its Board of Directors / Trustees, Executive Committee and Council. ISAC Council consists of the Executive Committee members and representatives from its Member Societies and meets at least every two years in conjunction with its biennial congress; the International Congress of Antimicrobial Chemotherapy (ICC).
ISAC is a registered charity in England and Wales, UK (Charity Commission registration number 1139367) and a company limited by guarantee (Companies House, England and Wales, UK registration number 7251522).
ISAC currently has 22 Working Groups and actively encourages and / or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective therapy. Of note, the Alliance for the Prudent Use of Antibiotics (APUA), which was founded in 1981, merged with ISAC in 2019 and has consolidated ISAC’s aims to refine its focus towards antimicrobial stewardship and antimicrobial resistance.
ISAC owns / co-owns two journals: the International Journal of Antimicrobial Agents (IF 5.283) and the Journal of Global Antimicrobial Resistance (IF 4.035). The society is in the process of launching the “ISAC Academy”. Its aims to move its biennial ICC around the globe; the 32nd ICC will be held in Australian in November 2022.
Menarini is committed to the fight against antimicrobial resistance (AMR), a serious threat to global public health. We are working collaboratively with partners to champion good stewardship and to share best practice in reducing the impact of AMR.
Since 2019 we have made available 3 antibiotics for healthcare professionals and their patients to tackle difficult-to-treat pathogens. Menarini supports the responsible use of antibiotics through a range of antimicrobial stewardship programmes.